Utah Medical Products (NASDAQ:UTMD) Given News Sentiment Score of 0.11

News stories about Utah Medical Products (NASDAQ:UTMD) have been trending somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Utah Medical Products earned a news impact score of 0.11 on Accern’s scale. Accern also assigned press coverage about the medical instruments supplier an impact score of 47.0701046230578 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Receive News & Ratings for Utah Medical Products Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

UTMD has been the topic of several research reports. BidaskClub lowered shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. ValuEngine raised shares of Utah Medical Products from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th.

Shares of Utah Medical Products (NASDAQ:UTMD) traded up 1.66% during trading on Monday, reaching $70.45. 16,038 shares of the company traded hands. The firm’s 50 day moving average price is $71.40 and its 200-day moving average price is $65.46. Utah Medical Products has a 52 week low of $56.30 and a 52 week high of $75.00. The company has a market capitalization of $262.00 million, a price-to-earnings ratio of 20.20 and a beta of 0.74.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be given a dividend of $0.265 per share. This represents a $1.06 annualized dividend and a yield of 1.50%. The ex-dividend date is Thursday, September 14th. Utah Medical Products’s payout ratio is currently 30.37%.

TRADEMARK VIOLATION NOTICE: This story was reported by [[site]] and is the sole property of of [[site]]. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at [[permalink]].

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.